Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial

INTRODUCTION: Calcium pyrophosphate deposition (CPPD) may cause severe arthropathy, major joint destruction and treatment options are limited. The aim of this study was to test the therapeutic efficacy of methotrexate (MTX) in chronic or recurrent CPPD arthropathy. METHODS: Patients with CPPD arthro...

Descripción completa

Detalles Bibliográficos
Autores principales: Finckh, Axel, Mc Carthy, Geraldine M, Madigan, Anne, Van Linthoudt, Daniel, Weber, Marcel, Neto, David, Rappoport, Georges, Blumhardt, Sandra, Kyburz, Diego, Guerne, Pierre-Andre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223155/
https://www.ncbi.nlm.nih.gov/pubmed/25315665
http://dx.doi.org/10.1186/s13075-014-0458-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223155/
https://www.ncbi.nlm.nih.gov/pubmed/25315665
http://dx.doi.org/10.1186/s13075-014-0458-4

Ejemplares similares